405 results on '"Coupé, Veerle M. H."'
Search Results
2. A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework
3. A Bayesian accelerated failure time model for interval censored three-state screening outcomes
4. Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trial
5. Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands
6. The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study
7. KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
8. Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer.
9. Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer
10. Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
11. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
12. Benefit-Harm Analysis for Informed Decision Making on Participating in Colorectal Cancer Screening: A Modeling Study
13. Benefit-harm analysis for informed decision making on participating in colorectal cancer screening: A Modeling Study
14. Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer
15. An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles
16. A Bayesian accelerated failure time model for interval censored three-state screening outcomes
17. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study
18. Efficacy and cost-utility of the eHealth self-management application 'Oncokompas', helping partners of patients with incurable cancer to identify their unmet supportive care needs and to take actions to meet their needs: a study protocol of a randomized controlled trial
19. Prevalence of adjustment disorder among cancer patients, and the reach, effectiveness, cost-utility and budget impact of tailored psychological treatment: study protocol of a randomized controlled trial
20. Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
21. Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?
22. Development and validation of a decision model for the evaluation of novel lung cancer treatments in the Netherlands
23. Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas:A Nested Case-Control Study
24. Efficacy and cost-utility of the eHealth application ‘Oncokompas’, supporting patients with incurable cancer in finding optimal palliative care, tailored to their quality of life and personal preferences: a study protocol of a randomized controlled trial
25. Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study
26. Inventory of oncologists’ unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer
27. Abstract A004: Molecular adenoma features to predict metachronous colorectal cancer risk: A nested-case control study
28. Size and shape of the associations of glucose, HbA1c, insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study
29. Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review
30. Cost-Utility of the eHealth Application ‘Oncokompas’, Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial
31. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial
32. Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening
33. Sensitivity Analysis for Threshold Decision Making with Bayesian Belief Networks
34. Long-term Impact of Human Papillomavirus Vaccination on Infection Rates, Cervical Abnormalities, and Cancer Incidence
35. sj-pdf-1-mdm-10.1177_0272989X211016307 – Supplemental material for Choosing a Metamodel of a Simulation Model for Uncertainty Quantification
36. Definition of competence standards for optical diagnosis of diminutive colorectal polyps: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
37. Methodological framework for development of competence standards for optical diagnosis in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
38. Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative
39. Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
40. Close Surveillance with Long-Term Follow-up of Subjects with Preinvasive Endobronchial Lesions
41. Choosing a Metamodel of a Simulation Model for Uncertainty Quantification
42. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing
43. sj-docx-1-mdm-10.1177_0272989X211016307 – Supplemental material for Choosing a Metamodel of a Simulation Model for Uncertainty Quantification
44. sj-pdf-1-tag-10.1177_1756284821995715 – Supplemental material for Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
45. Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative
46. Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers
47. Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
48. Longitudinal effects of adjuvant chemotherapy and related neuropathy on HU in stage II and III colon cancer patients: A prospective cohort study
49. Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review
50. The cost effectiveness of elective laparoscopic sigmoid resection for symptomatic diverticular disease: financial outcome of the randomized control Sigma trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.